DXCM DexCom, Inc.
DexCom, Inc. (DXCM) is expected to report earnings on October 29, 2026, after the market close. The consensus earnings estimate is $0.66 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +12.4% since its last earnings release on July 30, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About DexCom, Inc.
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
Sector
Healthcare
Industry
Medical Instruments/Supply